SCHEMBL9117366

SCHEMBL9117366

COC(=O)Cc1cc(O)c(Br)cc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 1/20 0.52
HKDC1 Q2TB90 1/20 0.52
HSP90AB1 P08238 1/20 0.46
EGFR P00533 2/20 0.46
ALDH1A1 P00352 4/20 0.42
GAA P10253 2/20 0.42
GFER P55789 1/20 0.42
KDM4E B2RXH2 4/20 0.40
GLA P06280 2/20 0.40
HPGD P15428 2/20 0.40
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38
HMGCR P04035 1/20 0.37
PRKCE Q02156 1/20 0.37
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
KMT2A Q03164 1/20 0.36
PDGFRB P09619 1/20 0.36
FGFR1 P11362 1/20 0.36
PDGFRA P16234 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13283682 0.89 HSP90AB1 (0.55) CCR6HKDC1HSP90AB1EGFRALDH1A1
SCHEMBL31463372 0.88 CCR6 (0.46) CCR6HKDC1HSP90AB1EGFRALDH1A1
SCHEMBL27176850 0.86 EGFR (0.43) CCR6HKDC1HSP90AB1EGFRALDH1A1
SCHEMBL22800077 0.83 HSP90AB1 (0.43) CCR6HKDC1HSP90AB1EGFRALDH1A1
SCHEMBL15760019 0.81 HSP90AB1 (0.48) CCR6HKDC1HSP90AB1EGFRALDH1A1
SCHEMBL4634542 0.81 ALDH1A1 (0.50) CCR6HKDC1HSP90AB1EGFRALDH1A1
SCHEMBL3835763 0.80 HSP90AB1 (0.47) CCR6HSP90AB1EGFRALDH1A1GAA
SCHEMBL4634387 0.79 EGFR (0.41) CCR6HKDC1HSP90AB1EGFRALDH1A1
SCHEMBL9126180 0.79 HMGCR (0.50) HSP90AB1EGFRALDH1A1GAAGFER
SCHEMBL1096417 0.78 MTNR1A (0.49) HSP90AB1EGFRALDH1A1GAAGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995025712-A1 HOMOGENTISIC ACID DERIVATIVES, METHODS OF TREATMENT OF DISEASE STATES MEDIATED BY PROTEIN KINASE C USING HOMOGENTISIC ACID DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS THEREOF SMITHKLINE BEECHAM CORPORATION (US) 1995-09-28 WO disclosed